Olink inleder strategiskt samarbete med Tataa

Olink, som utvecklar avancerade lösningar inom proteinanalys, inleder ett strategiskt samarbete med det snabbväxande labbföretaget Tataa Biocenter och lanserar plattformen Olink Explore 3072.

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, about 90 patients in Sweden have now been treated with this method. “Almost half of them have become disease-free, at least of those treated with Yescarta, which are the ones I know best,” says Gunilla Enblad, Chairman of the national working group for CAR-T treatment.

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridiculed by the medical establishment. However, from our perspective today, we can sum it up with the saying: He who laughs last laughs best, writes Samuel Lagercrantz in an editorial.

Björn Arvidsson: ”We need to change perspective”

If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network will generate as many versions as the people you ask. Most likely, we will miss many opportunities with our lack of communication, writes Björn Arvidsson in a column.

A new international stem cell research centre has been created in Copenhagen

A new centre for stem cell research opened to the public in January. The Novo Nordisk Foundation backs the initiative with the ambition that the centre will advance new medical technology and new stem cell therapies.

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure that new medicines will be available for all citizens in Europe, writes Marie Gårdmark in a column.

BMS stämmer svenskt forskningsbolag för patentintrång

Den globala läkemedelsjätten Bristol-Myers Squibb (BMS) stämmer det svenska forskningsbolaget Xspray Pharma för patentintrång kopplat till läkemedelskandidaten Dasynoc.

Lundbeck behind the first EU-approved intravenous migraine treatment

A preventive, intravenous treatment for migraines has been approved in the EU for the first time.

Hon får nyinrättade professuren i Health Governance

Ewa Wikström får den nyinrättade professuren i Health Governance på Handelshögskolan vid Göteborgs universitet. Professuren skapas med hjälp av Carl Bennet, huvudägare i bland annat Getinge, Arjo och Lifco, samt en särskild satsning från Göteborgs universitet.

GMS i samarbete med tyskt center inom precisionsmedicin

Centers for Personalized Medicine i Tyskland är ett av Europas ledande center inom precisionsmedicin. Nu går de in i ett samarbete med Genomic Medicine Sweden.

Study: An objective diagnosis of constant tinnitus may be possible

A new method that measures brain activity during sound stimulation can make it possible to objectively diagnose and identify people who suffer from constant tinnitus, which was demonstrated in a study made by researchers at the Karolinska Institute.

Bioarctic gör flera tunga rekryteringar: "Tid att växla upp"

Bioarctic, som utvecklar en behandling mot Alzheimers sjukdom, gör flera rekryteringar inför en kommande ansökan om marknadsgodkännande. – Bioarctic tar nu det första steget för att etablera sig som ett komplett biofarmabolag, säger bolagets vd Gunilla Osswald.

“Together Stockholm-Uppsala and Medicon Valley can make Scandinavia a leading life science region”

“Denmark, Sweden, Norway and Finland all have national life science strategies, but the Swedish strategy is the only one explicitly emphasizing the Nordic dimension. But what if the leading life science nations, Denmark and Sweden, joined forces, took the lead and pioneered Nordic life science collaboration? Wouldn´t we then be able to "bake a bigger cake?", writes Anette Steenberg and Ulf G. Andersson in a debate article.

Stockholm aims at becoming one of the world’s top life science regions

Regional Chair for Finance, Irene Svenonius (M), believes that Stockholm can realise the goal of becoming one of the world’s top 5 regions in life science by 2025. One step on the way to achieve this is by hosting a world-leading congress in medtech.

The route to vaccines for everyone: “We did not just sit around and wait”

The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a proposal, and Richard Bergström did not hesitate. “I already had a notion that this would work,” he says in an interview with Life Science Sweden.

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Lockdown-studie kritiseras även i USA

I USA har den uppmärksammade metastudie som uppger att knappt några liv har räddats med hjälp av lockdowns blivit kraftigt ifrågasatt av forskare.

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively – we need to engage bravely with the politics of poverty and scarcity. Even in life sciences", writes Giulia Gaudenzi in a column.

Irene Svenonius: ”Vi har urstarka förutsättningar att förverkliga målet inom life science"

Finansregionrådet Irene Svenonius (M) tror att Stockholm kan nå målet att höra till världens topp 5 regioner inom life science till år 2025. Och en del i att nå målet är att bli värdstad för en världsledande kongress inom medtech.

Planen: Så ska Stockholm bli en ledande life science-stad

Stockholm vill bli värdstad för en av de största internationella kongresserna om medicinteknik. Planen är en del i ambitionen att bli en av de mest framstående regionerna inom life science i världen.

Pharmiva stärker sin organisation

Pharmiva tillsätter Karolina Akerjordet som ny vice vd och Andrea Mildner som Head of Marketing and Sales.

Scibase rekryterar från Elekta

Theranos-skandalen – så gick det till när Elizabeth Holmes lurade USA:s toppinvesterare

Biotechbolaget Theranos var ett av de mest hyllade amerikanska företagen och dess vd Elizabeth Holmes blev en av USA:s yngsta miljardärer. Men 2015 vände allt för den framgångsrika entreprenören och sedan gick det bara utför. I början av den här månaden dömdes hon för bedrägeri av en domstol i Kalifornien.

Ilya Pharma utvecklar behandling mot bieffekter av immunterapier mot cancer

Uppsalaföretaget Ilya Pharma planerar att inleda kliniska studier med sin läkemedelskandidat ILP100-Oral för patienter som drabbats av enterokolit, tunn- och tjocktarmsinflammation, till följd av cancerbehandling.